Legal framework of antimicrobial stewardship in hospitals (LEASH): a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) cross-sectional international survey

Antimicrobial stewardship (AMS) is defined as a coherent set of actions designed to use antimicrobials responsibly [1,2]. AMS interventions include multiple activities that involve a broad range of stakeholders ranging from individual prescribers to healthcare systems and supranational incentives and regulators. AMS has been historically driven by professionals who were aware of the problem and were willing to use their expertise to improve antimicrobial prescribing. However, to be effective, the wider healthcare community, the regulators, and the general public must recognize the need for and value of AMS [3].

Source: International Journal of Antimicrobial Agents - July 28, 2018 Category: Drugs & Pharmacology Authors: Bojana Beovi ć, Céline Pulcini, Catherine Dumartin, Guillaume Béraud, Barbara Nerat, Cristina Maurel, May Doušak, Milan Čižman, the LEASH Study Group on behalf of ESCMID Study Group for Antimicrobial StewardshiP (ESGAP) Source Type: research